An automated system that identifies high-risk osteoporosis patients being treated for fractures and can generate letters encouraging follow-up is an effective way to promote osteoporosis intervention and prevent future fractures, ...
Jan 28, 2014
0
0
(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue of Spine.
Dec 30, 2013
0
0
A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic ...
Nov 28, 2013
0
0
University of Sydney researchers have discovered a promising treatment for osteoporosis, which is easily delivered in water soluble form.
Nov 21, 2013
0
0
The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System (LUHS). These findings were ...
Oct 31, 2013
0
0
(HealthDay)—As the population ages, experts expect the number of women with the bone-thinning disease osteoporosis to surge.
Oct 18, 2013
0
0
Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, ...
Oct 17, 2013
0
0
Osteoporosis, a disease that causes bones to weaken and sometimes break, is often thought of as a "women's disease," but it poses a significant threat to more than 2 million men in the United States, according to the National ...
Oct 9, 2013
0
0
A new exercise program trialled by Deakin University's Centre for Physical Activity and Nutrition Research in collaboration with the University of Melbourne could be the answer to reducing the risk of osteoporosis and fractures ...
Oct 7, 2013
0
0
(HealthDay)—Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.
Oct 4, 2013
0
0
